Research location
Moreno Valley
California, United States
Advertisement
Research activity in Moreno Valley
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 24 trials and 24 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Moreno Valley
24 linked trials · page 1 of 1Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaNCT06307665 · 2024-05-20 · 1 site observation
RECRUITING
Deep Brain Stimulation (DBS) Retrospective Outcomes StudyNCT03664609 · 2019-03-12 · 1 site observation
RECRUITING
Validation of SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary EmbolismNCT05568927 · 2022-11-15 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesNCT04255433 · 2020-05-29 · 1 site observation
COMPLETED
Does Ultrasound Assessment for Extravascular Lung Water and IVC Measurement Affect Outcomes in Inpatient Heart Failure Management?NCT04436718 · 2019-08-01 · 1 site observation
UNKNOWN
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 DiabetesNCT03811561 · 2019-05-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityNCT03574597 · 2018-10-24 · 1 site observation
COMPLETED
A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic DrugsNCT03078478 · 2017-03-13 · 1 site observation
COMPLETED
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusNCT02465515 · 2015-07-01 · 1 site observation
COMPLETED
Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION)NCT02191137 · 2014-09-23 · 1 site observation
COMPLETED
OPsumit USers RegistryNCT02126943 · 2014-04-30 · 1 site observation
COMPLETED
Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care SettingNCT02189395 · 2013-04-01 · 1 site observation
TERMINATED
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 DiabetesNCT01541215 · 2012-11-13 · 1 site observation
COMPLETED
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes MellitusNCT01494987 · 2012-01-01 · 1 site observation
COMPLETED
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 HypertensionNCT01508026 · 2012-01-01 · 1 site observation
COMPLETED
Ranolazine Monotherapy in Subjects With Type 2 Diabetes MellitusNCT01472185 · 2011-11-01 · 1 site observation
COMPLETED
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable AnginaNCT01425359 · 2011-09-01 · 1 site observation
COMPLETED
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesNCT00229658 · 2005-09-01 · 1 site observation
COMPLETED
Placebo and Active Controlled Study of Rivoglitazone in Type 2 DiabetesNCT00143520 · 2004-12-01 · 1 site observation
COMPLETED
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin AloneNCT00095030 · 2004-02-01 · 1 site observation
COMPLETED
Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 DiabetesNCT00111540 · 2002-11-01 · 1 site observation
COMPLETED
Extension Study for 2993-112NCT01789957 · 2002-09-01 · 1 site observation
COMPLETED
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes MellitusNCT00044694 · 2002-08-01 · 1 site observation
COMPLETED
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes MellitusNCT00035984 · 2002-05-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.